只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-16 2026-06-17 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入（P） | 61,523 | US$24.98 | US$153.68万 | 6,444,637 | SEC |
| 2026-06-16 2026-06-17 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter TenPercentOwner | 买入（P） | 61,523 | US$24.98 | US$153.68万 | 6,444,637 | SEC |
| 2026-06-16 2026-06-17 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 61,523 | US$24.98 | US$153.68万 | 6,444,637 | SEC |
| 2026-06-16 2026-06-17 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. TenPercentOwner | 买入（P） | 61,523 | US$24.98 | US$153.68万 | 6,444,637 | SEC |
| 2026-06-15 2026-06-17 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入（P） | 6,146 | US$24.89 | US$152,973.94 | 6,383,114 | SEC |
| 2026-06-15 2026-06-17 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter TenPercentOwner | 买入（P） | 6,146 | US$24.89 | US$152,973.94 | 6,383,114 | SEC |
| 2026-06-15 2026-06-17 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 6,146 | US$24.89 | US$152,973.94 | 6,383,114 | SEC |
| 2026-06-15 2026-06-17 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. TenPercentOwner | 买入（P） | 6,146 | US$24.89 | US$152,973.94 | 6,383,114 | SEC |
| 2026-05-20 2026-05-21 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入（P） | 996 | US$24.94 | US$24,840.24 | 6,376,968 | SEC |
| 2026-05-20 2026-05-21 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 996 | US$24.94 | US$24,840.24 | 6,376,968 | SEC |
| 2026-05-20 2026-05-21 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. TenPercentOwner | 买入（P） | 996 | US$24.94 | US$24,840.24 | 6,376,968 | SEC |
| 2026-05-20 2026-05-21 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter TenPercentOwner | 买入（P） | 996 | US$24.94 | US$24,840.24 | 6,376,968 | SEC |
| 2026-05-19 2026-05-21 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入（P） | 3,802 | US$24.97 | US$94,935.94 | 6,375,972 | SEC |
| 2026-05-19 2026-05-21 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 3,802 | US$24.97 | US$94,935.94 | 6,375,972 | SEC |
| 2026-05-19 2026-05-21 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. TenPercentOwner | 买入（P） | 3,802 | US$24.97 | US$94,935.94 | 6,375,972 | SEC |
| 2026-05-19 2026-05-21 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter TenPercentOwner | 买入（P） | 3,802 | US$24.97 | US$94,935.94 | 6,375,972 | SEC |
| 2026-05-12 2026-05-14 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter TenPercentOwner | 买入（P） | 6,387 | US$24.90 | US$159,036.30 | 6,372,170 | SEC |
| 2026-05-12 2026-05-14 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. TenPercentOwner | 买入（P） | 6,387 | US$24.90 | US$159,036.30 | 6,372,170 | SEC |
| 2026-05-12 2026-05-14 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 6,387 | US$24.90 | US$159,036.30 | 6,372,170 | SEC |
| 2026-05-12 2026-05-14 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入（P） | 6,387 | US$24.90 | US$159,036.30 | 6,372,170 | SEC |
| 2026-05-11 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 25,720 | US$25.00 | US$643,000.00 | 6,365,783 | SEC |
| 2026-05-11 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入（P） | 25,720 | US$25.00 | US$643,000.00 | 6,365,783 | SEC |
| 2026-05-11 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. TenPercentOwner | 买入（P） | 25,720 | US$25.00 | US$643,000.00 | 6,365,783 | SEC |
| 2026-05-11 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter TenPercentOwner | 买入（P） | 25,720 | US$25.00 | US$643,000.00 | 6,365,783 | SEC |
| 2026-05-11 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 14,149 | US$24.47 | US$346,226.03 | 6,340,063 | SEC |
| 2026-05-11 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入（P） | 14,149 | US$24.47 | US$346,226.03 | 6,340,063 | SEC |
| 2026-05-11 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. TenPercentOwner | 买入（P） | 14,149 | US$24.47 | US$346,226.03 | 6,340,063 | SEC |
| 2026-05-11 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter TenPercentOwner | 买入（P） | 14,149 | US$24.47 | US$346,226.03 | 6,340,063 | SEC |
| 2026-05-08 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 1,483 | US$24.98 | US$37,045.34 | 6,325,914 | SEC |
| 2026-05-08 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入（P） | 1,483 | US$24.98 | US$37,045.34 | 6,325,914 | SEC |
| 2026-05-08 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. TenPercentOwner | 买入（P） | 1,483 | US$24.98 | US$37,045.34 | 6,325,914 | SEC |
| 2026-05-08 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter TenPercentOwner | 买入（P） | 1,483 | US$24.98 | US$37,045.34 | 6,325,914 | SEC |
| 2026-05-07 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 1,985 | US$24.95 | US$49,525.75 | 6,324,431 | SEC |
| 2026-05-07 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入（P） | 1,985 | US$24.95 | US$49,525.75 | 6,324,431 | SEC |
| 2026-05-07 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. TenPercentOwner | 买入（P） | 1,985 | US$24.95 | US$49,525.75 | 6,324,431 | SEC |
| 2026-05-07 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter TenPercentOwner | 买入（P） | 1,985 | US$24.95 | US$49,525.75 | 6,324,431 | SEC |
| 2026-05-07 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP TenPercentOwner | 买入（P） | 7,921 | US$24.34 | US$192,797.14 | 6,322,446 | SEC |
| 2026-05-07 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. TenPercentOwner | 买入（P） | 7,921 | US$24.34 | US$192,797.14 | 6,322,446 | SEC |
| 2026-05-07 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. TenPercentOwner | 买入（P） | 7,921 | US$24.34 | US$192,797.14 | 6,322,446 | SEC |
| 2026-05-07 2026-05-11 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter TenPercentOwner | 买入（P） | 7,921 | US$24.34 | US$192,797.14 | 6,322,446 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 53,407 | US$24.83 | US$132.61万 | 6,314,525 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 53,407 | US$24.83 | US$132.61万 | 6,314,525 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund II, L.P. Director | 买入（P） | 53,407 | US$24.83 | US$132.61万 | 6,314,525 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund IV, L.P. Director | 买入（P） | 53,407 | US$24.83 | US$132.61万 | 6,314,525 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 53,407 | US$24.83 | US$132.61万 | 6,314,525 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 53,407 | US$24.83 | US$132.61万 | 6,314,525 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 14,611 | US$23.77 | US$347,303.47 | 6,261,118 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 14,611 | US$23.77 | US$347,303.47 | 6,261,118 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund II, L.P. Director | 买入（P） | 14,611 | US$23.77 | US$347,303.47 | 6,261,118 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund IV, L.P. Director | 买入（P） | 14,611 | US$23.77 | US$347,303.47 | 6,261,118 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 14,611 | US$23.77 | US$347,303.47 | 6,261,118 | SEC |
| 2026-05-06 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 14,611 | US$23.77 | US$347,303.47 | 6,261,118 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 10,268 | US$25.00 | US$256,700.00 | 6,246,507 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 10,268 | US$25.00 | US$256,700.00 | 6,246,507 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund II, L.P. Director | 买入（P） | 10,268 | US$25.00 | US$256,700.00 | 6,246,507 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund IV, L.P. Director | 买入（P） | 10,268 | US$25.00 | US$256,700.00 | 6,246,507 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 10,268 | US$25.00 | US$256,700.00 | 6,246,507 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 10,268 | US$25.00 | US$256,700.00 | 6,246,507 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 87,143 | US$24.59 | US$214.28万 | 6,236,239 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 87,143 | US$24.59 | US$214.28万 | 6,236,239 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund II, L.P. Director | 买入（P） | 87,143 | US$24.59 | US$214.28万 | 6,236,239 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund IV, L.P. Director | 买入（P） | 87,143 | US$24.59 | US$214.28万 | 6,236,239 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 87,143 | US$24.59 | US$214.28万 | 6,236,239 | SEC |
| 2026-05-05 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 87,143 | US$24.59 | US$214.28万 | 6,236,239 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 133,750 | US$18.00 | US$240.75万 | 354,938 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 133,750 | US$18.00 | US$240.75万 | 354,938 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund II, L.P. Director | 买入（P） | 133,750 | US$18.00 | US$240.75万 | 354,938 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund IV, L.P. Director | 买入（P） | 133,750 | US$18.00 | US$240.75万 | 354,938 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 133,750 | US$18.00 | US$240.75万 | 354,938 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 133,750 | US$18.00 | US$240.75万 | 354,938 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Shah Rajeev M. Director,TenPercentOwner | 买入（P） | 2,541,250 | US$18.00 | US$4574.25万 | 6,149,096 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Healthcare Fund LP Director,TenPercentOwner | 买入（P） | 2,541,250 | US$18.00 | US$4574.25万 | 6,149,096 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund II, L.P. Director | 买入（P） | 2,541,250 | US$18.00 | US$4574.25万 | 6,149,096 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA Capital Nexus Fund IV, L.P. Director | 买入（P） | 2,541,250 | US$18.00 | US$4574.25万 | 6,149,096 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | Kolchinsky Peter Director,TenPercentOwner | 买入（P） | 2,541,250 | US$18.00 | US$4574.25万 | 6,149,096 | SEC |
| 2026-05-04 2026-05-06 | COAG Hemab Therapeutics Holdings, Inc. | RA CAPITAL MANAGEMENT, L.P. Director,TenPercentOwner | 买入（P） | 2,541,250 | US$18.00 | US$4574.25万 | 6,149,096 | SEC |
| 2026-04-21 2026-04-22 | AGRO Adecoagro S.A. | Deprati Christian Ferdinando Emilio Director | 卖出（S） | 1,163 | US$13.03 | US$15,153.89 | 8,775 | SEC |
| 2026-04-21 2026-04-22 | AGRO Adecoagro S.A. | Larriera Andres Eduardo Director | 卖出（S） | 1,163 | US$13.03 | US$15,153.89 | 8,775 | SEC |
| 2026-04-21 2026-04-22 | AGRO Adecoagro S.A. | Vaz Artigas Manuela Director | 卖出（S） | 1,163 | US$13.03 | US$15,153.89 | 10,735 | SEC |
| 2026-04-21 2026-04-22 | AGRO Adecoagro S.A. | Sarjanovic Ivo Director | 卖出（S） | 1,163 | US$13.03 | US$15,153.89 | 21,561 | SEC |
| 2026-04-21 2026-04-22 | AGRO Adecoagro S.A. | Louis Dreyfus Kyril Robert Leonid Director | 卖出（S） | 1,163 | US$13.03 | US$15,153.89 | 8,661 | SEC |
| 2026-04-21 2026-04-22 | AGRO Adecoagro S.A. | Leon Bentancor Oscar Alejandro Director | 卖出（S） | 1,163 | US$13.03 | US$15,153.89 | 8,775 | SEC |
| 2026-04-07 2026-04-08 | AGRO Adecoagro S.A. | Vaz Artigas Manuela Director | 卖出（S） | 1,000 | US$15.03 | US$15,030.00 | 6,084 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| COAG | 144,267.5717 | 0 | 185,675.8863 | 77.70% | B, Q, N |